Cargando…

Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer

BACKGROUND AND OBJECTIVE: Differentiated thyroid carcinoma (DTC) is a slow-growing tumour with 20% of the cases having distant metastasis. Its prognosis can vary by its histological characteristics, extension and spread. The data on metastatic DTC patients in Pakistan is scarce; therefore, the purpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Abdul, Khan, Sajjad Ali, Suchal, Zafar A., Islam, Najmul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302427/
https://www.ncbi.nlm.nih.gov/pubmed/35873927
http://dx.doi.org/10.4103/ijem.ijem_455_21
_version_ 1784751633536647168
author Aziz, Abdul
Khan, Sajjad Ali
Suchal, Zafar A.
Islam, Najmul
author_facet Aziz, Abdul
Khan, Sajjad Ali
Suchal, Zafar A.
Islam, Najmul
author_sort Aziz, Abdul
collection PubMed
description BACKGROUND AND OBJECTIVE: Differentiated thyroid carcinoma (DTC) is a slow-growing tumour with 20% of the cases having distant metastasis. Its prognosis can vary by its histological characteristics, extension and spread. The data on metastatic DTC patients in Pakistan is scarce; therefore, the purpose of our study was to assess the clinicopathological characteristics and treatment outcomes of metastatic DTC in our population. METHODS: This retrospective, single-centre study was carried out on 117 patients with metastatic DTC with their age at diagnosis, gender, tumour size and extent and spread of the tumour, and its histologic characteristic recorded. The treatment they received and the outcome in terms of status, at last, follow-up were also recorded. RESULTS: The mean age of diagnosis was found to be 46.6 ± 17.2 years with an almost equal male to female ratio. The most common site of metastasis was the lung followed by bone. Papillary carcinoma was the most common subtype with 89.7% of the cases followed by follicular carcinoma occurring in 7.7%. The overall survival in years was found to be 5.6 ± 2.6 years. Ninety-six per cent had complete surgical resection followed by radioactive iodine (RAI) in 91.5%. CONCLUSION: Our study shows that the most significant factors in predicting the outcome in metastatic DTC are age, an extrathyroidal extension of the primary tumour and distant metastasis. However, further multicentric studies done on a much larger population will be needed to further support and strengthen our results.
format Online
Article
Text
id pubmed-9302427
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93024272022-07-22 Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer Aziz, Abdul Khan, Sajjad Ali Suchal, Zafar A. Islam, Najmul Indian J Endocrinol Metab Original Article BACKGROUND AND OBJECTIVE: Differentiated thyroid carcinoma (DTC) is a slow-growing tumour with 20% of the cases having distant metastasis. Its prognosis can vary by its histological characteristics, extension and spread. The data on metastatic DTC patients in Pakistan is scarce; therefore, the purpose of our study was to assess the clinicopathological characteristics and treatment outcomes of metastatic DTC in our population. METHODS: This retrospective, single-centre study was carried out on 117 patients with metastatic DTC with their age at diagnosis, gender, tumour size and extent and spread of the tumour, and its histologic characteristic recorded. The treatment they received and the outcome in terms of status, at last, follow-up were also recorded. RESULTS: The mean age of diagnosis was found to be 46.6 ± 17.2 years with an almost equal male to female ratio. The most common site of metastasis was the lung followed by bone. Papillary carcinoma was the most common subtype with 89.7% of the cases followed by follicular carcinoma occurring in 7.7%. The overall survival in years was found to be 5.6 ± 2.6 years. Ninety-six per cent had complete surgical resection followed by radioactive iodine (RAI) in 91.5%. CONCLUSION: Our study shows that the most significant factors in predicting the outcome in metastatic DTC are age, an extrathyroidal extension of the primary tumour and distant metastasis. However, further multicentric studies done on a much larger population will be needed to further support and strengthen our results. Wolters Kluwer - Medknow 2022 2022-06-06 /pmc/articles/PMC9302427/ /pubmed/35873927 http://dx.doi.org/10.4103/ijem.ijem_455_21 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Aziz, Abdul
Khan, Sajjad Ali
Suchal, Zafar A.
Islam, Najmul
Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer
title Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer
title_full Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer
title_fullStr Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer
title_full_unstemmed Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer
title_short Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer
title_sort clinicopathological characteristics and treatment outcome of patients with metastatic differentiated thyroid cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302427/
https://www.ncbi.nlm.nih.gov/pubmed/35873927
http://dx.doi.org/10.4103/ijem.ijem_455_21
work_keys_str_mv AT azizabdul clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer
AT khansajjadali clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer
AT suchalzafara clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer
AT islamnajmul clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer